Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0024582
DC FieldValue
dc.titleGene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma
dc.contributor.authorIvanovska, I.
dc.contributor.authorZhang, C.
dc.contributor.authorLiu, A.M.
dc.contributor.authorWong, K.F.
dc.contributor.authorLee, N.P.
dc.contributor.authorLewis, P.
dc.contributor.authorPhilippar, U.
dc.contributor.authorBansal, D.
dc.contributor.authorBuser, C.
dc.contributor.authorScott, M.
dc.contributor.authorMao, M.
dc.contributor.authorPoon, R.T.P.
dc.contributor.authorFan, S.T.
dc.contributor.authorCleary, M.A.
dc.contributor.authorLuk, J.M.
dc.contributor.authorDai, H.
dc.date.accessioned2014-11-26T09:59:41Z
dc.date.available2014-11-26T09:59:41Z
dc.date.issued2011-09-16
dc.identifier.citationIvanovska, I., Zhang, C., Liu, A.M., Wong, K.F., Lee, N.P., Lewis, P., Philippar, U., Bansal, D., Buser, C., Scott, M., Mao, M., Poon, R.T.P., Fan, S.T., Cleary, M.A., Luk, J.M., Dai, H. (2011-09-16). Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS ONE 6 (9) : -. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0024582
dc.identifier.issn19326203
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/110741
dc.description.abstractBiomarkers derived from gene expression profiling data may have a high false-positive rate and must be rigorously validated using independent clinical data sets, which are not always available. Although animal model systems could provide alternative data sets to formulate hypotheses and limit the number of signatures to be tested in clinical samples, the predictive power of such an approach is not yet proven. The present study aims to analyze the molecular signatures of liver cancer in a c-MET-transgenic mouse model and investigate its prognostic relevance to human hepatocellular carcinoma (HCC). Tissue samples were obtained from tumor (TU), adjacent non-tumor (AN) and distant normal (DN) liver in Tet-operator regulated (TRE) human c-MET transgenic mice (n = 21) as well as from a Chinese cohort of 272 HBV- and 9 HCV-associated HCC patients. Whole genome microarray expression profiling was conducted in Affymetrix gene expression chips, and prognostic significances of gene expression signatures were evaluated across the two species. Our data revealed parallels between mouse and human liver tumors, including down-regulation of metabolic pathways and up-regulation of cell cycle processes. The mouse tumors were most similar to a subset of patient samples characterized by activation of the Wnt pathway, but distinctive in the p53 pathway signals. Of potential clinical utility, we identified a set of genes that were down regulated in both mouse tumors and human HCC having significant predictive power on overall and disease-free survival, which were highly enriched for metabolic functions. In conclusions, this study provides evidence that a disease model can serve as a possible platform for generating hypotheses to be tested in human tissues and highlights an efficient method for generating biomarker signatures before extensive clinical trials have been initiated. © 2011 Ivanovska et al.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1371/journal.pone.0024582
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.1371/journal.pone.0024582
dc.description.sourcetitlePLoS ONE
dc.description.volume6
dc.description.issue9
dc.description.page-
dc.identifier.isiut000295173800028
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Mar 26, 2020

WEB OF SCIENCETM
Citations

15
checked on Mar 26, 2020

Page view(s)

67
checked on Mar 28, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.